Abstract: The present invention relates to a polypeptide binding to mucin 1, an isolated polynucleotide encoding same, a vector carrying the polynucleotide, and a cell including the vector. In addition, the present invention relates to a chimeric antigen receptor including the polypeptide binding to mucin 1, an isolated polynucleotide encoding the chimeric antigen receptor, a vector carrying the polynucleotide, an immune cell expressing the chimeric antigen receptor, a composition comprising same for treatment of cancer, and a method for treatment of cancer.
| # | Name | Date |
|---|---|---|
| 1 | 202317042769-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [26-06-2023(online)].pdf | 2023-06-26 |
| 2 | 202317042769-STATEMENT OF UNDERTAKING (FORM 3) [26-06-2023(online)].pdf | 2023-06-26 |
| 3 | 202317042769-Sequence Listing in txt [26-06-2023(online)].txt | 2023-06-26 |
| 4 | 202317042769-Sequence Listing in PDF [26-06-2023(online)].pdf | 2023-06-26 |
| 5 | 202317042769-REQUEST FOR EXAMINATION (FORM-18) [26-06-2023(online)].pdf | 2023-06-26 |
| 6 | 202317042769-PROOF OF RIGHT [26-06-2023(online)].pdf | 2023-06-26 |
| 7 | 202317042769-PRIORITY DOCUMENTS [26-06-2023(online)].pdf | 2023-06-26 |
| 8 | 202317042769-POWER OF AUTHORITY [26-06-2023(online)].pdf | 2023-06-26 |
| 9 | 202317042769-FORM 18 [26-06-2023(online)].pdf | 2023-06-26 |
| 10 | 202317042769-FORM 1 [26-06-2023(online)].pdf | 2023-06-26 |
| 11 | 202317042769-DRAWINGS [26-06-2023(online)].pdf | 2023-06-26 |
| 12 | 202317042769-DECLARATION OF INVENTORSHIP (FORM 5) [26-06-2023(online)].pdf | 2023-06-26 |
| 13 | 202317042769-COMPLETE SPECIFICATION [26-06-2023(online)].pdf | 2023-06-26 |
| 14 | 202317042769-RELEVANT DOCUMENTS [27-06-2023(online)].pdf | 2023-06-27 |
| 15 | 202317042769-MARKED COPIES OF AMENDEMENTS [27-06-2023(online)].pdf | 2023-06-27 |
| 16 | 202317042769-FORM 13 [27-06-2023(online)].pdf | 2023-06-27 |
| 17 | 202317042769-AMMENDED DOCUMENTS [27-06-2023(online)].pdf | 2023-06-27 |
| 18 | 202317042769-FORM 3 [21-11-2023(online)].pdf | 2023-11-21 |